CVE-2026-100560OpenClaw before 2026.8.1 Reusable Exec Approvals Authorization Bypass
Updated under an hour ago ()
Does this affect you?
It affects OpenClaw. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
OpenClaw versions before 2026.8.1 contain an authorization bypass vulnerability where Allow Always approvals for exact commands persist as path-only grants on macOS and Linux. Attackers can reuse the same executable with different arguments to execute commands without triggering new approval prompts, potentially accessing files or internal services.
- CVSS
- 7.5 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:H/PR:N/UI:R/S:U/C:H/I:H/A:H
- Weakness (CWE)
- CWE-863
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- VulnCheck
- NVD analysis
- Deferred
- Record last updated
- Sep 30, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
OpenClaw OpenClaw openclaw:openclaw (from the name) | before 2026.8.1; 2026.8.1 not affected | CNA record |
References
- https://github.com/openclaw/openclaw/security/advisories/GHSA-74gc-hg2m-79p9vendor-advisory
- https://www.vulncheck.com/advisories/openclaw-before-2026.8.1-reusable-exec-approvals-authorization-bypassthird-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.